2-(2-Methoxy-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

(2E)-N,N-Dimethyl-3-(pyridin-4-yl)prop-2-enamide, 95.0%, 100g

(R)-(3-Pyrrolidin-2-yl-propyl)-carbamic acid tert-butyl ester, 95.0%, 250mg

2-Cyanomethyl-5-trifluoromethylpyridine, 95.0%, 1g

tert-butyl {1-[amino(imino)methyl]-3-pyrrolidinyl}carbamate hydrochloride hydrate, 95.0%, 5g

2-(Trifluoromethoxy)benzaldehyde, 98.0%, 500g

Wide mouth bottle square clear glass, 250 ml, 45, short form, 10 Piece(s)

(2-METHYLCYCLOHEXYL)METHANAMINE, 95.0%, 2g

5-Bromo-2-methoxynicotinic acid, 98.0%, 100g

Sodium (Z)-5-(2-carbamoylhydrazono)-1-methyl-6-oxo-2,3,5,6-tetrahydro-1H-indole-2-sulfonate, 95.0%, 1g

2-(2,5-bis(Trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 250mg

GC capillary column ROTI®Cap-5 MS Ultra, 60 m, 0.25 mm, 1.00 µm, 1 Piece(s)

2-Methyl-1,4,5,6-tetrahydrobenzo[b]imidazo[4,5-d]azepine, 95.0%, 1g